CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Blood flow restrictiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04635579
NCT04635579N/ACompleted
CompareCT.gov

Personalized Blood Flow Restriction for Anterior Cruciate Ligament Rehabilitation

University of Washington·interventional·Posted Nov 19, 2020·Updated Feb 28, 2022

In Brief

A clinical study evaluating Blood flow restriction for Anterior Cruciate Ligament Tear. Completed, enrolled 40 participants across 1 site.

Detailed Summary

This is a cross-sectional study on the use of personalized blood flow restriction during rehabilitation exercises and its effects on biomechanics on people who have had an anterior cruciate ligament reconstruction and healthy controls

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnterior Cruciate Ligament Tear
CountriesUnited States
CollaboratorsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 19, 2020
Enrollment StartMay 8, 2018
Primary CompletionNov 2, 2020
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 5.6 years ago

Interventions

Blood flow restrictiondevice

Intervention restricts blood flow to the lower limb as a percentage of the limb occlusion pressure